NCT04895475View on ClinicalTrials.gov

Antibody Detection of Vaccine-Induced Secretory Effects

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

February 19, 2021

Primary Completion Date

May 10, 2022

Study Completion Date

August 31, 2023

Conditions
Covid19Humoral Acquired ImmunodeficiencyCoronavirusSARS-CoV Infection
Interventions
BEHAVIORAL

SARS-CoV-2 vaccine

Baseline demographics, baseline breast milk samples, and blood collection will be obtained at the initial visit. Serial collections of breastmilk and blood as well as weekly self-administered monthly surveys will occur

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT04895475 - Antibody Detection of Vaccine-Induced Secretory Effects | Biotech Hunter | Biotech Hunter